Gan & Lee Pharmaceuticals. (SHA:603087)
China · Delayed Price · Currency is CNY 59.21
+0.10 (0.17%)
Mar 26, 2026, 11:15 AM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 35.18 billion as of March 25, 2026. Its market cap has increased by 28.21% in one year.
Market Cap
35.18B
Enterprise Value
32.02B
Revenue
3.85B
Ranking
n/a
PE Ratio
37.56
Stock Price
59.21
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has decreased from 36.57B to 35.18B, a decrease of -3.80%. That is a compound annual growth rate of -0.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 35.18B | -13.16% |
| Dec 31, 2025 | 40.52B | 53.87% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imeik Technology Development | 38.85B |
| Intco Medical Technology | 36.36B |
| Andon Health | 26.18B |
| Zhende Medical | 24.64B |
| iRay Group | 23.89B |
| Winner Medical | 19.41B |
| Shenyang Xingqi Pharmaceutical | 16.72B |
| Jiangsu Hualan New Pharmaceutical Material | 14.14B |